Inverse association between Helicobacter pylori infection and childhood asthma in a physical examination population: a cross-sectional study in Chongqing, China
Abstract:Background
Childhood asthma has substantial effects on children's health. It is important to identify factors in early life that influence childhood asthma. Accumulating evidence indicates that Helicobacter pylori may protect against allergic diseases. This study aimed to evaluate the relationship between H. pylori infection and pediatric asthma in Chongqing, China.
Materials and methods
This cross-sectional study included healthy children aged 4–1… Show more
“…The relative abundance of Proteobacteria phylum and Firmicutes: Bacteroidetes ratio was related to the stability of microbial community, pro‐inflammatory response, and energy metabolism, which played an important role on maintaining gut microbial homeostasis, 50 the expansion of Proteobacteria was concluded to be a potential marker for unstable microbial community and some metabolic and immune disease in a review, 51 increased value of Firmicutes/Bacteroidetes was found in animal models of NAFLD, 52 but their role on maintaining stomach microbial homeostasis remained unknown. In our study, the abundance of Proteobacteria and Firmicutes: Bacteroidetes ratio declined significantly in H. pylori ‐infected patients, which may illustrate the protective effect of H. pylori on inflammatory bowel disease and child asthma 53‐55 . Firmicutes:Bacteroidetes ratio might be a potential marker for inflammation of gastric mucous, increased value of Firmicutes/Bacteroidetes may represent a higher risk of oncogenesis.…”
Section: Discussionsupporting
confidence: 56%
“…In our study, the abundance of Proteobacteria and Firmicutes: Bacteroidetes ratio declined significantly in H. pylori-infected patients, which may illustrate the protective effect of H. pylori on inflammatory bowel disease and child asthma. [53][54][55] Firmicutes:Bacteroidetes ratio might be a potential marker for inflammation of gastric mucous, increased value of Firmicutes/Bacteroidetes may represent a higher risk of oncogenesis. The infection of H. pylori may be a result of individual gastric flora disturbance, such as the imbalance of Firmicutes and Bacteroidetes.…”
Background
Most patients with Helicobacter pylori (H. pylori) infection have no clinical symptoms, numerous studies reported the gastric microbiome in H. pylori‐infected patients, but asymptomatic patients have not been distinguished. How the microbiome and function changes in asymptomatic patients with H. pylori infection remains poorly understood.
Methods
A total of 29 patients were divided into H. pylori‐infected asymptomatic group (10 patients), H. pylori‐infected symptomatic group (11 patients) and H. pylori‐uninfected group (8 patients). Gastric mucosa specimens were taken for histopathological examination, special staining, and 16 S rDNA sequencing. High‐throughput results were evaluated by community composition analysis, indicator species analysis, alpha diversity analysis, beta diversity analysis, and function prediction.
Results
The gastric microbiota composition at phylum and genus level of H. pylori‐infected asymptomatic patients were similar with H. pylori‐infected symptomatic group, but different from H. pylori‐uninfected patients. The diversity and richness of gastric microbial community declined significantly in H. pylori‐infected asymptomatic group comparing with H. pylori‐uninfected group. Sphingomonas may be an indicator between symptomatic and asymptomatic patients with H. pylori infection, the AUC value of Sphingomonas is 0.79. Interactions between species increased and altered notably after H. pylori infection. More genera were affected by Helicobacter in H. pylori‐infected asymptomatic patients. The function condition changed significantly in asymptomatic patients with H. pylori infection, there was no difference comparing with symptomatic ones. Amino acid metabolism and lipid metabolism strengthened but carbohydrate metabolism remained constant after H. pylori infection. The metabolism of fatty acid and bile acid was disturbed after infection with H. pylori.
Conclusion
The gastric microbiota composition and function mode changed significantly after H. pylori infection regardless of the presence of clinical symptoms, there was no difference between H. pylori‐infected asymptomatic and symptomatic patients. The difference in gastric microbiota composition and interactions between species might be responsible for presence of digestive symptoms.
“…The relative abundance of Proteobacteria phylum and Firmicutes: Bacteroidetes ratio was related to the stability of microbial community, pro‐inflammatory response, and energy metabolism, which played an important role on maintaining gut microbial homeostasis, 50 the expansion of Proteobacteria was concluded to be a potential marker for unstable microbial community and some metabolic and immune disease in a review, 51 increased value of Firmicutes/Bacteroidetes was found in animal models of NAFLD, 52 but their role on maintaining stomach microbial homeostasis remained unknown. In our study, the abundance of Proteobacteria and Firmicutes: Bacteroidetes ratio declined significantly in H. pylori ‐infected patients, which may illustrate the protective effect of H. pylori on inflammatory bowel disease and child asthma 53‐55 . Firmicutes:Bacteroidetes ratio might be a potential marker for inflammation of gastric mucous, increased value of Firmicutes/Bacteroidetes may represent a higher risk of oncogenesis.…”
Section: Discussionsupporting
confidence: 56%
“…In our study, the abundance of Proteobacteria and Firmicutes: Bacteroidetes ratio declined significantly in H. pylori-infected patients, which may illustrate the protective effect of H. pylori on inflammatory bowel disease and child asthma. [53][54][55] Firmicutes:Bacteroidetes ratio might be a potential marker for inflammation of gastric mucous, increased value of Firmicutes/Bacteroidetes may represent a higher risk of oncogenesis. The infection of H. pylori may be a result of individual gastric flora disturbance, such as the imbalance of Firmicutes and Bacteroidetes.…”
Background
Most patients with Helicobacter pylori (H. pylori) infection have no clinical symptoms, numerous studies reported the gastric microbiome in H. pylori‐infected patients, but asymptomatic patients have not been distinguished. How the microbiome and function changes in asymptomatic patients with H. pylori infection remains poorly understood.
Methods
A total of 29 patients were divided into H. pylori‐infected asymptomatic group (10 patients), H. pylori‐infected symptomatic group (11 patients) and H. pylori‐uninfected group (8 patients). Gastric mucosa specimens were taken for histopathological examination, special staining, and 16 S rDNA sequencing. High‐throughput results were evaluated by community composition analysis, indicator species analysis, alpha diversity analysis, beta diversity analysis, and function prediction.
Results
The gastric microbiota composition at phylum and genus level of H. pylori‐infected asymptomatic patients were similar with H. pylori‐infected symptomatic group, but different from H. pylori‐uninfected patients. The diversity and richness of gastric microbial community declined significantly in H. pylori‐infected asymptomatic group comparing with H. pylori‐uninfected group. Sphingomonas may be an indicator between symptomatic and asymptomatic patients with H. pylori infection, the AUC value of Sphingomonas is 0.79. Interactions between species increased and altered notably after H. pylori infection. More genera were affected by Helicobacter in H. pylori‐infected asymptomatic patients. The function condition changed significantly in asymptomatic patients with H. pylori infection, there was no difference comparing with symptomatic ones. Amino acid metabolism and lipid metabolism strengthened but carbohydrate metabolism remained constant after H. pylori infection. The metabolism of fatty acid and bile acid was disturbed after infection with H. pylori.
Conclusion
The gastric microbiota composition and function mode changed significantly after H. pylori infection regardless of the presence of clinical symptoms, there was no difference between H. pylori‐infected asymptomatic and symptomatic patients. The difference in gastric microbiota composition and interactions between species might be responsible for presence of digestive symptoms.
“…In a cross-sectional study that included 2241 participants, the rates of asthma diagnosis were 7.23% among H. pylori -negative children and 3.77% among H. pylori -positive children. This result indicates a significant inverse correlation between H. pylori infection and asthma ( Wang et al., 2022a ). This protective effect by H. pylori is supported by three hypotheses, including the gut-lung axis theory, the “disappearing microbiota” hypothesis, and the hygiene hypothesis ( Strachan, 2000 ; Taube and Müller, 2012 ; Wypych et al., 2019 ).…”
Helicobacter pylori, a gram-negative microaerophilic pathogen, causes several upper gastrointestinal diseases, such as chronic gastritis, peptic ulcer disease, and gastric cancer. For the diseases listed above, H. pylori has different pathogenic mechanisms, including colonization and virulence factor expression. It is essential to make accurate diagnoses and provide patients with effective treatment to achieve positive clinical outcomes. Detection of H. pylori can be accomplished invasively and noninvasively, with both having advantages and limitations. To enhance therapeutic outcomes, novel therapeutic regimens, as well as adjunctive therapies with probiotics and traditional Chinese medicine, have been attempted along with traditional empiric treatments, such as triple and bismuth quadruple therapies. An H. pylori infection, however, is difficult to eradicate during treatment owing to bacterial resistance, and there is no commonly available preventive vaccine. The purpose of this review is to provide an overview of our understanding of H. pylori infections and to highlight current treatment and diagnostic options.
“…Epidemiological studies have shown a decline in the prevalence of H. pylori infection in the Western World and in some developing countries in contrast to an increase in the incidence of asthma and allergic diseases [ 8 ]. Studies have demonstrated that H. pylori infection can prevent asthma [ 9 , 10 ], and it has been noted that CagA-positive H. pylori infection is significantly negatively associated with the risk of asthma [ 11 , 12 ] and may even be negatively associated with the severity of asthma [ 11 ]. A meta-analysis of 18 cross-sectional studies found that H. pylori infection, especially CagA-positive H. pylori infection, was inversely associated with the prevalence of asthma [ 13 ].…”
Section: Association Between H Pylori Infection and The Risk Of Aller...mentioning
H. pylori is a gram-negative bacterium that is usually acquired in childhood and can persistently colonize the gastric mucosa of humans, affecting approximately half of the world’s population. In recent years, the prevalence of H. pylori infection has steadily reduced while the risk of allergic diseases has steadily climbed. As a result, epidemiological research indicates a strong negative association between the two. Moreover, numerous experimental studies have demonstrated that eradicating H. pylori increases the risk of allergic diseases. Hence, it is hypothesized that H. pylori infection may act as a safeguard against allergic diseases. The hygiene hypothesis, alterations in gut microbiota, the development of tolerogenic dendritic cells, and helper T cells could all be involved in H. pylori’s ability to protect against asthma. Furthermore, Studies on mice models have indicated that H. pylori and its extracts are crucial in the management of asthma. We reviewed the in-depth studies on the most recent developments in the relationship between H. pylori infection and allergic diseases, and we discussed potential mechanisms of the infection’s protective effect on asthma in terms of microbiota and immunity. We also investigated the prospect of the application of H. pylori and its related components in asthma, so as to provide a new perspective for the prevention or treatment of allergic diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.